Trial Outcomes & Findings for Effect of a Patient-Centered Decision App on TOLAC (NCT NCT02646423)

NCT ID: NCT02646423

Last Updated: 2021-02-02

Results Overview

Number of participants who underwent a trial of labor after cesarean (TOLAC) delivery, as noted in the medical record.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1485 participants

Primary outcome timeframe

0-8 weeks after delivery

Results posted on

2021-02-02

Participant Flow

Participant milestones

Participant milestones
Measure
Prior CD Decision App (PCDDA)
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
Women randomized to the Usual Care - No App group will simply continue with usual care.
Overall Study
STARTED
742
743
Overall Study
COMPLETED
735
735
Overall Study
NOT COMPLETED
7
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Prior CD Decision App (PCDDA)
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
Women randomized to the Usual Care - No App group will simply continue with usual care.
Overall Study
Adverse Event
5
7
Overall Study
Ineligible
2
1

Baseline Characteristics

Effect of a Patient-Centered Decision App on TOLAC

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Prior CD Decision App (PCDDA)
n=735 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=735 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Total
n=1470 Participants
Total of all reporting groups
Age, Continuous
34.1 years
STANDARD_DEVIATION 4.6 • n=5 Participants
34.0 years
STANDARD_DEVIATION 4.5 • n=7 Participants
34.0 years
STANDARD_DEVIATION 4.5 • n=5 Participants
Sex: Female, Male
Female
735 Participants
n=5 Participants
735 Participants
n=7 Participants
1470 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race or ethnic group · White
394 Participants
n=5 Participants
411 Participants
n=7 Participants
805 Participants
n=5 Participants
Race/Ethnicity, Customized
Race or ethnic group · Latina
124 Participants
n=5 Participants
124 Participants
n=7 Participants
248 Participants
n=5 Participants
Race/Ethnicity, Customized
Race or ethnic group · Asian or Pacific Islander
110 Participants
n=5 Participants
106 Participants
n=7 Participants
216 Participants
n=5 Participants
Race/Ethnicity, Customized
Race or ethnic group · Black
64 Participants
n=5 Participants
52 Participants
n=7 Participants
116 Participants
n=5 Participants
Race/Ethnicity, Customized
Race or ethnic group · Biracial or multiracial/multiethnic
23 Participants
n=5 Participants
25 Participants
n=7 Participants
48 Participants
n=5 Participants
Race/Ethnicity, Customized
Race or ethnic group · Other
20 Participants
n=5 Participants
17 Participants
n=7 Participants
37 Participants
n=5 Participants
Region of Enrollment
United States · University of California, San Francisco
192 Participants
n=5 Participants
193 Participants
n=7 Participants
385 Participants
n=5 Participants
Region of Enrollment
United States · Marin Community Clinic, San Rafael, California
26 Participants
n=5 Participants
25 Participants
n=7 Participants
51 Participants
n=5 Participants
Region of Enrollment
United States · St Luke's Women's Clinic, San Francisco
18 Participants
n=5 Participants
18 Participants
n=7 Participants
36 Participants
n=5 Participants
Region of Enrollment
United States · Massachusetts General Hospital, Boston
274 Participants
n=5 Participants
278 Participants
n=7 Participants
552 Participants
n=5 Participants
Region of Enrollment
United States · Northwestern University Medical Center, Chicago
225 Participants
n=5 Participants
221 Participants
n=7 Participants
446 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 0-8 weeks after delivery

Population: Prior CD Decision App (PCDDA): no data available for N=8 participants who delivered at outside institution and no chart or outside questionnaire obtained. Usual Care - No App: no data available for N=3 participants who delivered at outside institution and no chart or outside questionnaire obtained.

Number of participants who underwent a trial of labor after cesarean (TOLAC) delivery, as noted in the medical record.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=727 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=732 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Number of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) Delivery
315 Participants
338 Participants

SECONDARY outcome

Timeframe: 0 to 8 weeks after delivery

Population: Prior CD Decision App (PCDDA): no data available for N=8 participants who delivered at outside institution and no chart or outside questionnaire obtained. Usual Care - No App: no data available for N=3 participants who delivered at outside institution and no chart or outside questionnaire obtained.

Number of participants who underwent vaginal birth after cesarean (VBAC), as noted in the medical record.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=727 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=732 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Number of Participants Who Underwent Vaginal Birth After Cesarean (VBAC)
231 Participants
233 Participants

SECONDARY outcome

Timeframe: Approx 34-37 weeks gestation

Population: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained, 31 Could not be reached for follow-up, 26 Delivered prior to follow-up interview, 2 Had pregnancy loss ≥22 wk. Usual Care - No App: 681 Follow-up telephone interviews obtained, 31 Could not be reached for follow-up, 23 Delivered prior to follow-up interview.

8-item knowledge scale, administered during telephone interview. Scores ranged from 0 to 8 with higher scored indicating greater knowledge.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=676 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=681 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Knowledge About TOLAC and ERCD
5.0 score on a scale
Standard Deviation 1.8
5.0 score on a scale
Standard Deviation 1.7

SECONDARY outcome

Timeframe: Approx 34-37 weeks gestation

Population: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Conflict Scale missing for 5 participants with PCDAA. Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Conflict Scale missing for 6 participants with usual care.

16-item Decisional Conflict Scale with 5 response categories, administered during telephone interview. Scoring: total scale-0 (no decisional conflict) to 100 (extreme decisional conflict) lower values indicate lower decisional conflict.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=671 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=675 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Decisional Conflict
17.2 score on a scale
Standard Deviation 12.9
17.5 score on a scale
Standard Deviation 13.9

SECONDARY outcome

Timeframe: Approx 34-37 weeks gestation

Population: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Shared Decision Making Scale missing for 12 participants with PCDAA. Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Shared Decision Making Scale missing for 9 participants with usual care.

9-item Shared Decision Making Scale, administered during telephone interview. Shared decision-making was measured using the 9-item Shared Decision Making Questionnaire (SDM-Q-9), a psychometrically evaluated tool. The core instrument consists of nine statements, which can be rated on a six-point scale from "completely disagree" (0) to "completely agree" (5). The Shared Decision Score can range from 0 to 100, with higher scores indicating more shared decision-making.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=664 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=672 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Shared Decision Making
74.4 score on a scale
Standard Deviation 14.9
74.8 score on a scale
Standard Deviation 15.9

SECONDARY outcome

Timeframe: Approx 34-37 weeks gestation

Population: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Self-Efficacy Scale missing for 6 participants with PCDAA. Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Self-Efficacy Scale missing for 9 participants with PCDAA.

11-item Decisional Self-Efficacy Scale, administered during telephone interview. The total score is calculated by summing the 11 items, dividing by 11 and multiplying by 25. Scores range from 0 (not confident) to 100 (extremely confident).

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=670 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=672 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Decision Self-Efficacy
90.7 score on a scale
Standard Deviation 12.3
90.3 score on a scale
Standard Deviation 12.2

SECONDARY outcome

Timeframe: Approx 34-37 weeks gestation

Population: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Satisfaction Scale missing for 1 participant with PCDAA. Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Satisfaction Scale missing for 2 participants with PCDAA.

6-item Satisfaction with Decision Scale, administered during telephone interview. Satisfaction With Decision Scale scores range from 0 to 5, with higher scores indicating more satisfaction.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=675 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=679 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Decision Satisfaction
4.62 score on a scale
Standard Deviation 0.59
4.65 score on a scale
Standard Deviation 0.54

SECONDARY outcome

Timeframe: Collected 0 to 8 weeks after delivery.

Population: PCDDA: 15 delivered at outside institution and outcome for maternal major morbidity was not obtained. Usual Care- No app: 12 delivered at outside institution and outcome for maternal major morbidity was not obtained.

Defined as any of: uterine rupture, hysterectomy, surgical injury (bowel, bladder/ureter, or other), maternal death, as noted in the medical record for her delivery.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=720 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=723 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Maternal Major Morbidity
19 Participants
23 Participants

SECONDARY outcome

Timeframe: Collected 0 to 8 weeks after delivery.

Population: PCDDA: 15 Delivered at outside institution and maternal minor morbidity outcome not collected during chart review. 1 additional without complete chart review information. No App: 12 Delivered at outside institution and maternal minor morbidity outcome not collected during chart review. 1 additional without complete chart review information.

Defined as any of: blood transfusion, postpartum febrile morbidity (endometritis, cellulitis, urinary tract infection, or other infection), as noted in the medical record for her delivery.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=719 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=722 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Maternal Minor Morbidity
36 Participants
36 Participants

SECONDARY outcome

Timeframe: Collected 0 to 8 weeks after delivery.

Population: PCDDA: 15 delivered at outside institution and outcome for 3rd or 4th degree lacerations was not obtained. Usual Care- No app: 12 delivered at outside institution and outcome for 3rd or 4th degree lacerations was not obtained.

3rd or 4th degree lacerations, as noted in the medical record for her delivery.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=720 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=723 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
3rd or 4th Degree Lacerations
16 Participants
12 Participants

SECONDARY outcome

Timeframe: Collected 0 to 8 weeks after delivery.

Population: PCDDA: 15 delivered at outside institution and outcome for perinatal death or hypoxic-ischemic encephalopathy was not obtained from chart review. No app: 12 delivered at outside institution and outcome for perinatal death or hypoxic-ischemic encephalopathy was not obtained from chart review. 1 delivery at institution missing outcome from chart.

Stillbirth/fetal demise (antepartum or intrapartum), neonatal death, HIE, as noted in the medical record for her delivery.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=720 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=722 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Perinatal Death or Hypoxic-ischemic Encephalopathy
Neonatal death
2 participants
0 participants
Perinatal Death or Hypoxic-ischemic Encephalopathy
Intrauterine fetal demised
4 participants
0 participants
Perinatal Death or Hypoxic-ischemic Encephalopathy
Hypoxic-ischemic encephalopathy
2 participants
4 participants

SECONDARY outcome

Timeframe: Collected 0 to 8 weeks after delivery.

Population: PCDDA: 15 delivered at outside institution and neonatal respiratory morbidity was not obtained from chart review. 1 delivery at institution missing outcome from chart. No app: 12 delivered at outside institution and neonatal respiratory morbidity was not obtained from chart review. 2 deliveries at institution missing outcome from chart.

Respiratory morbidity requiring CPAP or intubation, as noted in the medical record for her delivery.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=719 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=721 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Neonatal Respiratory Morbidity
67 Participants
68 Participants

SECONDARY outcome

Timeframe: Collected 0 to 8 weeks after delivery.

Population: Prior CD Decision App (PCDDA): 15 delivered at outside institution and NICU admission was not obtained from chart review. Usual Care-No app: 12 delivered at outside institution and NICU admission was not obtained from chart review. 1 delivery at institution missing outcome from chart.

Neonatal intensive care unit (NICU) admission, as noted in the medical record for her delivery.

Outcome measures

Outcome measures
Measure
Prior CD Decision App (PCDDA)
n=720 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
Usual Care - No App
n=722 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
Neonatal Intensive Care Unit (NICU) Admission
98 Participants
87 Participants

Adverse Events

Prior CD Decision App (PCDDA)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care - No App

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Miriam Kupperman, PhD, MPH

University of California, San Francisco

Phone: 415-502-4089

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place